ロート製薬株式会社 · ROHTO PHARMACEUTICAL CO.,LTD.
Last · —$2893.00+63.00 (+2.23%)live · yahoo · 1h ago
Market cap——
P/E · TTM20.6fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | ¥343.7B |
|---|---|
| Operating income | ¥41.1B |
| Net income | ¥34.2B |
| Free cash flow | ¥32.8B |
| Operating margin | 12.0% |
| Net margin | 10.0% |
| Return on equity | 13.5% |
| Period | 2026 |
Loading chart…
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
$32.77
Est. revenue
89.2B
Earnings transcripts
Documents
FormReporting forFiledFlags